AgelessRx Research
Can Rapamycin Improve Gum Health?
Could Rapamycin support oral health as part of healthy aging? Explore how mTOR, gum disease, and early research may connect periodontal health to longevity.
Commercial Biobanking: What It Is and Why It Matters
Commercial biobanking stores your biological samples long-term for future research. Learn what it means for your longevity goals.
Rapamycin and DEXA Scans: Our Observational Study on Body Composition and Aging
AgelessRx tracked DEXA scan metrics in Rapamycin subscribers to study real-world changes in lean muscle, fat mass, and bone density.
AgelessRx Named XPRIZE Healthspan Milestone 2 Awardee and Awarded $1 Million to Advance Healthy Aging Clinical Trial
AgelessRx has been named one of 10 XPRIZE Healthspan finalists, earning a $1 million award to advance its research on extending healthy human lifespan.
Sleep, Aging & Our Observational Trial
Our Observational Sleep for Longevity Trial is now in analysis, exploring how sleep patterns connect to biological age.
AgelessRx: XPRIZE Healthspan Finalist
AgelessRx advanced to the XPRIZE Healthspan Finals in August 2026, bringing a data-driven 9-agent protocol targeting muscle, cognitive, and immune function.
AgelessRx + XPRIZE Healthspan Semi-Finals: Our 90-Day Trial Findings
AgelessRx's XPRIZE Healthspan 90-day pilot measured biological aging markers in a cohort of adults. Explore the key findings from our semi-finals longevity protocol
Canagliflozin as a Longevity Therapy: AgelessRx Trial Findings
A closer look at our Canagliflozin pilot trial, including the study design, metabolic findings, glucose response, and tolerability in healthy adults.
Low Dose Naltrexone for Healthspan: What Our Real-World Study Found
Explore how Low Dose Naltrexone may target inflammaging and support healthspan, based on real-world findings from 5,500 participants.